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HORMESIS [BIOLOGICAL EFFECTS OF LOW LEVEL EXPOSURES (BELLE)]
AND DERMATOLOGY
Haw-Yueh Thong, MD, MS, Howard I. Maibach, MD  Department of
Dermatology, University of California, School of Medicine, San Francisco, CA
 Hormesis, or biological effects of low level exposures (BELLE), is characterized by
nonmonotonic dose response which is biphasic, displaying opposite effects at low and
high dose. Its occurrence has been documented across a broad range of biological mod-
els and diverse type of exposure. Since hormesis appears to be a relatively common phe-
nomenon in many areas, the objective of this review is to explore its occurrence related to
dermatology and its public health and risk assessment implication. Hormesis appears to
be a common phenomenon in in-vitro skin biology. However, in vivo data are lacking and
the clinical relevance of hormesis has yet to be determined. Better understanding of this
phenomenon will likely lead to different strategies for risk assessment process employed
in the fields of dermatologic toxicology and pharmacology. We believe that hormesis is a
common phenomenon and should be given detailed consideration to its concept and its
risk assessment implications, and how these may be incorporated into the experimental
and regulatory processes in dermatology. The skin, with its unique characteristics, its
accessibility, and the availability of non-invasive bioengineering and DNA microarray tech-
nology, will be a good candidate to extend the biology of hormesis.
Keywords: Hormesis, biological effects of low level exposures (BELLE), biphasic dose-response rela-
tionships, dose response, dermatology, keratinocytes, melanocytes, fibroblasts, hair follicle, tumor cell
lines, toxicology, pharmacology
INTRODUCTION
Biphasic dose response, namely a low-dose stimulatory and a high-
dose inhibitory response, also called hormesis, or biological effects of low
level exposures (BELLE) in the field of toxicology, has been noted in a
wide range of biological model systems from immunology to cancer biol-
ogy (Calabrese and Baldwin 2001, 2003; Calabrese 2005a, 2005b).
Calabrese has been the mainstay in bringing the attention of the scientif-
ic community to this interesting and a not uncommon phenomenon
(Calabrese and Baldwin 2001, 2003; Calabrese 2005a, 2005b). As noted by
Calabrese, the quantitative features of the hormetic-like biphasic dose
response were remarkably similar with respect to the amplitude of the
stimulatory response, the width of the stimulation, and the relationship
of the maximum stimulatory response to the zero equivalent point (ZEP,
i.e. threshold). Typically, the low-dose hormetic biphasic dose response
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stimulation is modest, with maximum stimulation between 30 to 60%
greater than controls, and has a rather similar appearance in different
cell types with various chemicals (Calabrese 2005b). Most stimulatory
ranges were less than 100-fold (averages 10- to 20- fold) measuring back
from the ZEP. The low-dose stimulatory response often occurs following
an initial disruption in homeostatis and appears to represent a modest
overcompensation response. It is believed that the modest stimulatory
responsiveness is due to the result of a compensatory process that “slight-
ly” overshoots its goal of the original physiological set-point, ensuring that
the system returns to homeostasis without unnecessary and excessive
overcompensation (Calabrese 2001). Therefore, it is important to follow
the dose-response relationships overtime in order to better define its
quantitative features. While initial interest focused on the hormetic
effects of pollutants and toxic substances on biological systems (Calabrese
and Baldwin 1997), the interest expanded to include pharmacological
agents, phyto-compounds, as well as endogenous agonists (Calabrese
2005b). The hormetic- like biphasic dose response relationships appears
to be highly generalizable; that is, such responses do not appear to be
restricted by biological model, endpoint, or chemical/physical stressors
(Calabrese 2005b). 
Many investigations attempted to assess mechanisms that could
account for the hormetic-like biphasic dose-response relationship. In
general, there is no single mechanism that accounts for the plethora of
hormetic relationships. Nonetheless, a common molecular tactic by
which biphasic dose-response relationships are displayed involves the
presence of two receptor subtypes affecting cell regulation, one with high
and the other with low affinity for the agonist but with notably more
capacity (i.e. more receptors) (Calabrese 2005b). Such an arrangement
may lead to the biphasic dose response, with the high-affinity receptor
activated at low concentrations, which stimulates DNA synthesis and cel-
lular proliferation; and the low affinity/high-capacity receptor becoming
dominant at higher concentrations decreasing the cell proliferative
response. This is a general pharmacological mechanism in that it is
employed for a large number of receptor-based responses from cancer
cells to neutrophil chemotaxis and many others.
This article reviews hormetic effects of various agents on in vitro skin
biology. Recognition of this emerging biological phenomenon in derma-
tology should lead to markedly improved integrative assessments of ani-
mal/human skin responses to toxic substances, pharmacological agents,
as well as endogenous agonists.
EVIDENCES OF HORMESIS IN SKIN CULTURES 
Skin is a complex biological model but highly approachable. Models
exist for dermatologic research which include animal vs human skin
H.-Y. Thong and H. I. Maibach
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models, in vitro vs in vivo models, regional variation, stem cell biology and
hair follicle biology. Many pharmaceutical preparations in dermatology
affect cell regulation. Nonetheless, the FDA sometimes exempts dose jus-
tification for dermatologic preparations. As a result, the presence of any
hormetic effect might have been missed. 
The literature in dermatology indicates that several cell types in the
skin provided evidence of hormetic-like biphasic dose/concentration-
response relationships. A brief listing of the cell types showing hormetic
relationships and the quantitative features of dose responses is presented
in Table 1. 
MELANOMA AND TUMOR CELL LINES DISPLAY HORMETIC DOSE
RESPONSES
Perhaps a more important issue regarding hormesis is its relationship
to cancer biology. The existence of hormetic dose responses in many
tumor cell lines has been noted and reviewed by Calabrese(2005b). 12
melanoma cell lines (M4Beu, B16, M24, MNT, SK-MEL, H1144, SK-
MEL28, Cal 1, Cal 4, Cal 23, Cal 24, Cal 32) have been shown to display
hormetic dose responses to various chemicals (guanine or guanosine
derivatives, mistletoe extract, salsolinol, tetrahydropapaveroline,
dopamine, resveratrol, thrombin and suramin) (Calabrese 2005b).
Numerous endogenous agonists, drugs, environmental contaminants,
and phytochemicals, some relevant to dermato-toxicology and dermato-
oncology, have also been noted to exert hormetic dose responses in vari-
ous tumor cell lines (Calabrese 2005b). Examples and the proposed
mechanistic explanations are listed in Table 2. 
HORMESIS AND ITS IMPLICATION IN SKIN AGING 
Detailed molecular mechanisms of the hormetic effects on cell aging
are being increasingly understood. Studies have shown that repeated
mild heat stress (RMHS) has anti-aging effects on serially passaged
human fibroblasts throughout their replicative lifespan in vitro.
Treatment with RMHS at 41o C, for 1 hour twice a week, increased the lev-
els of various chaperones and antioxidant enzymes, increased the phos-
phorylation-mediated activities of various stress kinases, reduced the
accumulation of oxidatively and glycoxidatively damaged proteins, stimu-
lated proteasomal activities for the degradation of abnormal proteins,
improved cellular resistance to ethanol, hydrogen peroxide, and UV-B
rays. RMHS-treated aging human fibroblasts are also better protected
against glucose- and glyoxal-induced growth inhibition and apoptosis.
Various hormetic effects of RMHS were also noted on normal human epi-
dermal keratinocytes, including increased replicative life span, increased
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2004a; Rattan and Ali, 2007). While
some important issues with respect to
establishing the optimal hormetic
conditions are yet to be resolved by
future research, hormesis could be a
promising approach for modulating
aging (Rattan 2004b; Rattan 2004c).
DISCUSSION
Despite the acknowledgement of
the existence of hormesis, its impor-
tance has been disregarded by the sci-
entific community, with one of the
reasons being the close association of
the concept of hormesis with the
highly controversial medical practice
of homeopathy (Burgdorf and
Happle 1996; Clement 1997; Cook
and Calabrese 2006). 
Calabrese and Blain (2005) devel-
oped a hormesis database, containing
5600 hormetic-like dose response
relationships over approximately 900
agents from a broadly diversified spec-
trum of chemical classes and physical
agents, stressing the general robust-
ness of published studies to establish
support for the hormetic dose-
response hypothesis. Table 1 showed
that clear examples of hormesis do
exist in dermatology, and Table 2 sug-
gested that the presence of hormesis
in cancer biology may be an impor-
tant phenomenon not to be over-
looked. 
Despite the extensive observation
of hormetic dose-response relation-
ships for numerous agents across the
biological spectrum, most studies
assessed cellular responses. Few stud-
ies followed up in animal and human
models—normal or disease, or
assessed the simultaneous responses
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We believe in vivo studies are necessary to provide an integrative assess-
ment of the whole animal/human responses to various agents, to docu-
ment any discrepancies between the in vitro and in vivo responses, and to
clarify the clinical implication of hormesis. 
Studies on the mechanism of action and the exact definition of the
low-dose to be applied are essential to achieve a better understanding of
hormesis. Another important issue to discuss in the field of hormesis, as
proposed by van der Woude et al (2005), is the need for risk assessment
paradigms to be modified to take hormesis into account. Note that
research methods may need to be modified to take into account that using
lower doses and getting smaller responses may mean that a substantial
increase in the number of animals or test subjects may be needed to get
statistically significant results. Rietjens and Alink (2006) also suggested
that more focus should be redirect from looking only at adverse effects at
high levels of exposure to characterizing the complex biological effects,
both adverse and beneficial, at low levels of exposure. Low-dose toxicolo-
gy and pharmacology will contribute to better methods for low-dose risk
assessment of chemical compounds and their effect on carcinogenesis,
taking into consideration that the ultimate biological effect of a chemical
may vary with its dose, the endpoint or target organ considered, cellular
interactions, and/or the combined exposure with other chemicals.
We believe skin is an excellent candidate to gain entrance into this
biology due to its accessibility; its complex nature, with highly differenti-
ated cell types and various subsystems (keratinocytes, melanocytes,
Langerhans’ cells, fibroblasts, epidermis, dermis, hair follicle, eccrine,
apocrine and sebaceous units); and the availability of specialized non-
invasive technology for in vivo studies (Maibach 1996; Elsner et al. 2001).
In addition, skin has been among the first organs analyzed using DNA
microarrays in various topics from skin cancers, melanomas, basal cell
carcinomas, squamous cell carcinomas, psoriasis and other inflammatory
disorders, to stem cell biology, the biology of epidermal keratinocytes,
and so forth (Table 3) (Blumenberg 2006). DNA microarray studies will
be an excellent tool to elucidate the mechanisms of hormesis in skin biol-
ogy. In short, better understanding of hormesis will likely lead to differ-
ent strategies for risk assessment process employed in the fields of der-
matologic toxicology and pharmacology.
CONCLUSION
Hormesis is a common phenomenon in dermatology and other fields.
Detailed consideration should be given to its concept, its risk assessment
implications, and its clinical significance. However, without additional
mechanistic insight, the consequences of hormesis for risk assessment and
the possibilities for in vitro to in vivo extrapolation will remain limited. 
H.-Y. Thong and H. I. Maibach
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Skin can be an excellent candidate to study hormesis and its underly-
ing mechanisms because of its accessibility; its repertoire of inflammato-
ry and immunomodulating cytokines, hormones, vitamins, unique
responses to ultraviolet light, toxins, and physical injury; and the avail-
ability of non-invasive bioengineering and DNA microarray technology.
Artificial skin substitutes are also available to study the effects of harmful
or dangerous agents. In essence, the skin has everything: from stem cells,
signaling and cellular differentiation, to inflammation, diseases, and can-
cer. All these facets could become excellent models to further study
hormesis and its clinical implications following exposure to a variety of
toxic compounds and pharmaceutical agents. 
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